Suppr超能文献

红细胞膜疾病的诊断和临床管理。

Diagnosis and clinical management of red cell membrane disorders.

机构信息

Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.

出版信息

Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):331-340. doi: 10.1182/hematology.2021000265.

Abstract

Heterogeneous red blood cell (RBC) membrane disorders and hydration defects often present with the common clinical findings of hemolytic anemia, but they may require substantially different management, based on their pathophysiology. An accurate and timely diagnosis is essential to avoid inappropriate interventions and prevent complications. Advances in genetic testing availability within the last decade, combined with extensive foundational knowledge on RBC membrane structure and function, now facilitate the correct diagnosis in patients with a variety of hereditary hemolytic anemias (HHAs). Studies in patient cohorts with well-defined genetic diagnoses have revealed complications such as iron overload in hereditary xerocytosis, which is amenable to monitoring, prevention, and treatment, and demonstrated that splenectomy is not always an effective or safe treatment for any patient with HHA. However, a multitude of variants of unknown clinical significance have been discovered by genetic evaluation, requiring interpretation by thorough phenotypic assessment in clinical and/or research laboratories. Here we discuss genotype-phenotype correlations and corresponding clinical management in patients with RBC membranopathies and propose an algorithm for the laboratory workup of patients presenting with symptoms and signs of hemolytic anemia, with a clinical case that exemplifies such a workup.

摘要

红细胞(RBC)膜异型和水合缺陷通常表现为溶血性贫血的常见临床特征,但根据其病理生理学,它们可能需要截然不同的治疗方法。准确及时的诊断对于避免不适当的干预和预防并发症至关重要。在过去十年中,基因检测的可用性取得了进展,再加上对 RBC 膜结构和功能的广泛基础认识,现在可以为各种遗传性溶血性贫血(HHAs)患者做出正确的诊断。对具有明确遗传诊断的患者队列的研究揭示了遗传性血红细胞增多症中的铁过载等并发症,这些并发症可以通过监测、预防和治疗来解决,并且表明脾切除术并不总是任何 HHA 患者的有效或安全治疗方法。然而,通过基因评估发现了大量具有未知临床意义的变异,这需要在临床和/或研究实验室中通过彻底的表型评估来解释。在这里,我们讨论了 RBC 膜病变患者的基因型-表型相关性和相应的临床管理,并提出了一种用于出现溶血性贫血症状和体征的患者的实验室检查工作流程的算法,并通过一个临床病例来说明这种工作流程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f33/8791164/d274131f5ecb/hem.2021000265_s1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验